HoneyNaps Joins Eurostars Project on Non-Invasive Brain Pressure Monitoring

HoneyNaps, a South Korean sleep medicine AI company, has been selected for a 2026 Eurostars international R&D project to develop a non-invasive platform that monitors intracranial pressure and sleep status. The work will be carried out with partners in South Korea and Sweden.
- HoneyNaps was selected for a 2026 Eurostars international R&D project, according to the company.
- The consortium includes Yonsei University, Dankook University, Uppsala University and Xantage AB.
- The platform targets TRL 6 and combines a chip-scale VNA, SansEC microwave resonant sensors, physics-informed AI and wireless PSG analysis.
- It is intended to continuously estimate intracranial pressure changes and automatically analyze sleep stages and events.
- The project will prepare the technical and documentation framework for EU MDR submission.
A Korean-Swedish consortium
According to HoneyNaps, the selected project is titled "Development of a Spectroscopic Electromagnetic Sensing and Artificial Intelligence Platform for Non-Invasive Neurological Monitoring." Besides HoneyNaps, the consortium includes Yonsei University, Dankook University, Sweden's Uppsala University and Xantage AB.
Eurostars is a multilateral R&D funding programme operated by the Eureka Network and co-funded by the European Union. In Korea, the project is supported by the Ministry of Trade, Industry and Resources and the Korea Institute for Advancement of Technology (KIAT). The participants bring expertise in sensor technology, artificial intelligence and clinical platforms, the company said.
What the platform is meant to do
The consortium aims to develop and validate an integrated platform at Technology Readiness Level 6 (TRL 6). It is to combine several components:
- a compact chip-scale vector network analyzer (VNA)
- SansEC microwave resonant sensors
- physics-informed AI
- wireless polysomnography (PSG) signal analysis
The platform is intended to continuously estimate changes in intracranial pressure (ICP) and to automatically analyze sleep stages and events. The announcement describes skin-mounted sensors that track ICP changes continuously, alongside sleep signal analysis.
The project will also set up the technical and documentation framework needed to prepare for a submission under the European Union Medical Device Regulation (MDR).
HoneyNaps' role: wireless sleep signals
HoneyNaps will work on the wireless collection and analysis of electroencephalogram (EEG), electrooculogram (EOG), electromyogram (EMG), electrocardiogram (ECG), oxygen saturation (SpO₂) and respiratory signals. The stated goal is to combine the clinical information from laboratory-based PSG with the convenience of home-based testing, enabling automated analysis of sleep stages and key sleep events.
What it means
The announcement describes research and development work, not a finished product. Sean Ha (Taekyoung Ha), President of HoneyNaps USA, said: "By combining electromagnetic sensing with sleep biosignal analysis, this project will evaluate the potential of non-invasive neurological monitoring." He added that the partners "will validate the sensors, AI and platform in stages and build a foundation for clinical use and global market entry."
The release gives no timeline, funding amount or performance results. For now, the project signals HoneyNaps' intent to extend from sleep analysis into neurological monitoring, with the EU MDR groundwork pointing toward eventual regulatory submission.
PR Newswire: HoneyNaps Selected for 2026 Eurostars International R&D Project

